Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1381655

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1381655

Global Allergy Immunotherapy Market Size study & Forecast, by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ) by Allergy Type, by Distribution Channel and Regional Analysis, 2023-2030

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Allergy Immunotherapy Market is valued at approximately USD 2.07 billion in 2022 and is anticipated to grow with a growth rate of more than 9.0% over the forecast period 2023-2030. Allergy immunotherapy is a medical treatment for allergies. It is a long-term therapy that aims to desensitize a person's immune system to specific allergens, such as pollen, dust mites, pet dander, or certain insect venoms. The goal of allergy immunotherapy is to modify the immune response to allergens, leading to a reduction in allergy symptoms. It can be effective in treating allergic rhinitis (hay fever), allergic asthma, and insect venom allergies. Allergy shots can provide long-term relief, even after the treatment is completed. The Allergy Immunotherapy market is expanding because of factors such as the increasing burden of various types of allergies and rising demand for personalized medicine.

According to Information form the American College of Allergy, Asthma & Immunology, more than 50 million Americans suffer from allergies each year. In addition, for instance, a journal paper published by SingleCare in January 2022 estimates that more than 50.0 million Americans experience an allergy of some form each year. Similarly, The number of cases of asthma in Indian senior citizens across the India in 2050 was anticipated to be about 25.4 million cases. Furthermore, it noted that allergies rank as the sixth-most prevalent chronic illness in the US. In addition, a survey conducted by SingleCare in 2021 found that 82.0% of respondents who had allergies felt their allergies had an impact on their quality of life in the US. Thus, rising incidence of allergies across the regions is driving the market growth. In addition, technological advancements in sublingual dosage formulations and presence of strong product pipeline are creating a lucrative opportunity to the market growth. However, the high cost of allergy immunotherapy research and drawbacks associated with the use of allergy immunotherapy and availability of alternative treatments stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Allergy Immunotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of key market players, rising prevelance of allergy disorders, rising number of product launch activities in the region. Whereas, Asia Pacific region is projected to have fastest growth owing to factors such as rising disease prevelance, rising expansion by key market players in the region as well as rising number of awareness programs in the region.

Major market player included in this report are:

  • Torii Pharmaceutical Co., Ltd.
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Biomay AG
  • Allovate, LLC
  • HAL Allergy Group
  • Jubliant Pharma (Hollister Allergy)
  • Leti Pharma
  • Merck KGaA (Allergopharma)
  • Stallergenes Greer

Recent Developments in the Market:

  • In January 2023, HollisterStier Allergy unveiled Ultrafiltered Dog, its most recent product innovation. Patients who are sensitive to dogs can be diagnosed and treated successfully with the product.
  • In June 2022, ALK began a phase I clinical research in North America for their brand-new sublingual tablet intended to treat peanut allergy.

Global Allergy Immunotherapy Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Treatment Type, Allery Type, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

By Allergy Type:

  • Allergic rhinitis
  • Allergic asthma
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Allergy Immunotherapy Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Allergy Immunotherapy Market, by Treatment Type, 2020-2030 (USD Billion)
    • 1.2.3. Allergy Immunotherapy Market, by Allergy Type, 2020-2030 (USD Billion)
    • 1.2.4. Allergy Immunotherapy Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Allergy Immunotherapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Allergy Immunotherapy Market Dynamics

  • 3.1. Allergy Immunotherapy Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing burden of various types of allergies
      • 3.1.1.2. Rising demand for personalized medicine
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Allergy Immunotherapy
      • 3.1.2.2. Allergy Immunotherapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in sublingual dosage formulations
      • 3.1.3.2. Presence of strong product pipeline

Chapter 4. Global Allergy Immunotherapy Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Allergy Immunotherapy Market, by Treatment Type

  • 5.1. Market Snapshot
  • 5.2. Global Allergy Immunotherapy Market by Treatment Type, Performance - Potential Analysis
  • 5.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Billion)
  • 5.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 5.4.1. Subcutaneous Immunotherapy (SCIT)
    • 5.4.2. Sublingual Immunotherapy (SLIT)

Chapter 6. Global Allergy Immunotherapy Market, by Allergy Type

  • 6.1. Market Snapshot
  • 6.2. Global Allergy Immunotherapy Market by Allergy Type, Performance - Potential Analysis
  • 6.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Allergy Type 2020-2030 (USD Billion)
  • 6.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 6.4.1. Allergic rhinitis
    • 6.4.2. Allergic asthma
    • 6.4.3. Others

Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Allergy Immunotherapy Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy

Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Allergy Immunotherapy Market, Regional Market Snapshot
  • 8.4. North America Allergy Immunotherapy Market
    • 8.4.1. U.S. Allergy Immunotherapy Market
      • 8.4.1.1. Treatment Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Allergy Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Allergy Immunotherapy Market
  • 8.5. Europe Allergy Immunotherapy Market Snapshot
    • 8.5.1. U.K. Allergy Immunotherapy Market
    • 8.5.2. Germany Allergy Immunotherapy Market
    • 8.5.3. France Allergy Immunotherapy Market
    • 8.5.4. Spain Allergy Immunotherapy Market
    • 8.5.5. Italy Allergy Immunotherapy Market
    • 8.5.6. Rest of Europe Allergy Immunotherapy Market
  • 8.6. Asia-Pacific Allergy Immunotherapy Market Snapshot
    • 8.6.1. China Allergy Immunotherapy Market
    • 8.6.2. India Allergy Immunotherapy Market
    • 8.6.3. Japan Allergy Immunotherapy Market
    • 8.6.4. Australia Allergy Immunotherapy Market
    • 8.6.5. South Korea Allergy Immunotherapy Market
    • 8.6.6. Rest of Asia Pacific Allergy Immunotherapy Market
  • 8.7. Latin America Allergy Immunotherapy Market Snapshot
    • 8.7.1. Brazil Allergy Immunotherapy Market
    • 8.7.2. Mexico Allergy Immunotherapy Market
  • 8.8. Middle East & Africa Allergy Immunotherapy Market
    • 8.8.1. Saudi Arabia Allergy Immunotherapy Market
    • 8.8.2. South Africa Allergy Immunotherapy Market
    • 8.8.3. Rest of Middle East & Africa Allergy Immunotherapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Torii Pharmaceutical Co., Ltd.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. ALK-Abello A/S
    • 9.3.3. Allergy Therapeutics
    • 9.3.4. Biomay AG
    • 9.3.5. Allovate, LLC
    • 9.3.6. HAL Allergy Group
    • 9.3.7. Jubliant Pharma (Hollister Allergy)
    • 9.3.8. Leti Pharma
    • 9.3.9. Merck KGaA (Allergopharma)
    • 9.3.10. Stallergenes Greer

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Allergy Immunotherapy Market, report scope
  • TABLE 2. Global Allergy Immunotherapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Allergy Immunotherapy Market estimates & forecasts by Treatment Type 2020-2030 (USD Billion)
  • TABLE 4. Global Allergy Immunotherapy Market estimates & forecasts by Allergy Type 2020-2030 (USD Billion)
  • TABLE 5. Global Allergy Immunotherapy Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Allergy Immunotherapy Market
  • TABLE 71. List of primary sources, used in the study of global Allergy Immunotherapy Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Allergy Immunotherapy Market, research methodology
  • FIG 2. Global Allergy Immunotherapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Allergy Immunotherapy Market, key trends 2022
  • FIG 5. Global Allergy Immunotherapy Market, growth prospects 2023-2030
  • FIG 6. Global Allergy Immunotherapy Market, porters 5 force model
  • FIG 7. Global Allergy Immunotherapy Market, pest analysis
  • FIG 8. Global Allergy Immunotherapy Market, value chain analysis
  • FIG 9. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Allergy Immunotherapy Market, regional snapshot 2020 & 2030
  • FIG 15. North America Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Allergy Immunotherapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!